Publicaciones en colaboración con investigadores/as de University of Helsinki (26)

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Identification of ZBTB18 as a novel colorectal tumor suppressor gene through genome-wide promoter hypermethylation analysis

    Clinical Epigenetics, Vol. 13, Núm. 1

2012

  1. Brush border Myosin Ia has tumor suppressor activity in the intestine

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, Núm. 5, pp. 1530-1535

  2. Candidate driver genes in microsatellite-unstable colorectal cancer

    International Journal of Cancer, Vol. 130, Núm. 7, pp. 1558-1566

  3. Villin expression is frequently lost in poorly differentiated colon cancer

    American Journal of Pathology, Vol. 180, Núm. 4, pp. 1509-1521

2010

  1. Mutations in the circadian gene CLOCK in colorectal cancer

    Molecular Cancer Research, Vol. 8, Núm. 7, pp. 952-960

2009

  1. An A13 repeat within the 3′-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expression

    Cancer Research, Vol. 69, Núm. 19, pp. 7811-7818

  2. Metastasis-associated gene expression changes predict poor outcomes in patients with Dukes stage B and C colorectal cancer

    Clinical Cancer Research, Vol. 15, Núm. 24, pp. 7642-7651

2007

  1. Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis

    Oncogene, Vol. 26, Núm. 2, pp. 312-320

  2. Tumour selection advantage of non-dominant negative P53 mutations in homozygotic MDM2-SNP309 colorectal cancer cells

    Journal of Medical Genetics, Vol. 44, Núm. 1, pp. 75-80

2006

  1. A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition

    Nature Genetics, Vol. 38, Núm. 5, pp. 566-569

  2. Decrease in c-Myc activity enhances cancer cell sensitivity to vinblastine

    Anti-Cancer Drugs, Vol. 17, Núm. 2, pp. 181-187

  3. Distinct expression profile in fumarate-hydratase-deficient uterine fibroids

    Human Molecular Genetics, Vol. 15, Núm. 1, pp. 97-103

  4. EPHB4 and survival of colorectal cancer patients

    Cancer Research, Vol. 66, Núm. 18, pp. 8943-8948

  5. Modeling tumor predisposing FH mutations in yeast: Effects on fumarase activity, growth phenotype and gene expression profile

    International Journal of Cancer, Vol. 118, Núm. 6, pp. 1340-1345

2005

  1. 7q deletion mapping and expression profiling in uterine fibroids

    Oncogene, Vol. 24, Núm. 43, pp. 6545-6554

  2. Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer

    Gastroenterology, Vol. 129, Núm. 3, pp. 874-884

  3. Hypothetical Valuations of health states Versus patients' self-ratings

    EQ-5D Concepts and Methods: A Developmental History (Springer Netherlands), pp. 125-138

  4. Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors

    Cancer Research, Vol. 65, Núm. 22, pp. 10170-10173

  5. Mutations in two short noncoding mononucleotide repeats in most microsatellite-unstable colorectal cancers

    Cancer Research, Vol. 65, Núm. 11, pp. 4607-4613